---
title: Small Molecule Development & Manufacturing CDMOs in China
path: /services/small-molecule-development-manufacturing/china
companies_count: 9
---

# Small Molecule Development & Manufacturing CDMOs in China

9 published CDMOs match Small Molecule Development & Manufacturing in China.

Locations in this set include China, United States, Switzerland, Japan, France, and Netherlands.

Capabilities that show up most often in this set: Small Molecule, Antibody-Drug Conjugate (ADC), Peptide, Biologics (Other), and Oligonucleotide.

## Matching companies

- [Carbogen Amcis](/companies/carbogen-amcis)
  - Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.
- [Catalent](/companies/catalent)
  - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
- [PHT International, Inc.](/companies/phtinternational)
  - PHT International is a Contract Research, Development, and Manufacturing Organization (CRDMO) offering small-molecule process R&D, cGMP manufacturing from milligrams to multi-tons, and chemical sourcing with global facilities across North America, Europe, and Asia.
- [PharmaBlock](/companies/pharmablock)
  - Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Porton](/companies/portonpharma)
  - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
- [Roquette Pharma Solutions](/companies/roquette)
  - Roquette is a leading global provider of plant-based ingredients, excipients, and solutions for the pharmaceutical and healthcare industries.
- [Yongtai Technology](/companies/yongtaitech)
  - Yongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing.
- [重庆兴泰濠制药有限公司 (Sintaho)](/companies/sintaho)
  - China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.
